FATE Competitors & Alternatives
Compare Fate Therapeutics Inc with similar stocks in the same industry
Biotechnology
FATE
Main Stock$2.34
Tradestie Score
42
Market Cap
$144.16M
Revenue Growth
0.1%
Analyst Upside
+146.0%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CTNM
Contineum Therapeutics, Inc. Class A Common Stock
|
$13.09
|
$308.74M | - | 71 | Compare |
|
EPRX
Eupraxia Pharmaceuticals Inc. Common Stock
|
$7.62
|
$307.12M | - | 39 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$10.26
|
$304.12M | - | 59 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$13.58
|
$297.23M | - | 50 | Compare |
|
OMER
Omeros Corporation
|
$18.69
|
$281.75M | 11.5 | 51 | Compare |
|
DBVT
DBV Technologies S.A.
|
$10.85
|
$275.54M | - | 43 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$1.55
|
$275.13M | - | 44 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$18.82
|
$269.08M | 0.1 | 68 | Compare |
|
PBYI
PUMA BIOTECHNOLOGY INC
|
$9.84
|
$265.45M | 19.5 | 46 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 51 | Compare |
More FATE Analysis
Data updated: Oct 02, 2026 | Industry: Biotechnology (SIC 2836)
230 stocks in this industry